Finance

Lists
Why is VRAX down 5,69%?
Dive Deeper
VRAX:NASDAQ
Virax Biolabs Group Ltd
1,99 USD
-5,69%
(-0,12) 1D
8-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRAX...
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
50,76 миң
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
50,76 миң
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
News stories
From web sources and news partners
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersЛондон, Ингленд, Улуу Британия
SectorHealth care provider
Websiteviraxbiolabs.com
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
1,00 USD
-49,7%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
804,00
804,00
5,41 миң
5,41 миң
Cost of goods sold
161,00
161,00
2,21 миң
2,21 миң
Cost of revenue
161,00
161,00
2,21 миң
2,21 миң
Research and development expenses
689,87 миң
689,87 миң
1,18 млн
1,18 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
603,51 миң
603,51 миң
731,02 миң
731,02 миң
Operating expense
1,29 млн
1,29 млн
1,91 млн
1,91 млн
Total operating expenses
1,29 млн
1,29 млн
1,91 млн
1,91 млн
Operating income
-1,29 млн
-1,29 млн
-1,91 млн
-1,91 млн
Other non operating income
-201,00
-201,00
218,00
218,00
EBT including unusual items
-1,31 млн
-1,31 млн
-1,66 млн
-1,66 млн
EBT excluding unusual items
-1,31 млн
-1,31 млн
-1,66 млн
-1,66 млн
Income tax expense
-136,80 миң
-136,80 миң
-313,32 миң
-313,32 миң
Effective tax rate
10,46%
10,46%
18,90%
18,90%
Other operating expenses
-
-
-
-
Net income
-1,17 млн
-1,17 млн
-1,34 млн
-1,34 млн
Net profit margin
-145 446,02%
-145 446,02%
-24 824,13%
-24 824,13%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15,50 миң
-15,50 миң
-15,39 миң
-15,39 миң
Net interest expenses
-15,50 миң
-15,50 миң
-15,39 миң
-15,39 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,21 млн
-1,21 млн
-1,82 млн
-1,82 млн
Gain or loss from assets sale
213,00
213,00
15,88 миң
15,88 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору